Abstract:Abstract Background Current tobacco smoking is independently associated with decreased overall survival (OS) among patients with metastatic renal cell carcinoma (mRCC) treated with targeted monotherapy (VEGF-TKI). Herein, we assess the influence of smoking status on the outcomes of patients with mRCC treated with the current first-line standard of care of immune checkpoint inhibitor (ICI)-based regimens. Materials and Methods Real-world data from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) were collected retrospectively. Patients with mRCC who received either dual ICI therapy or ICI with VEGF-TKI in the first-line setting were included and were categorized as current, former, or nonsmokers. The primary outcomes were OS, time to treatment failure (TTF), and objective response rate (ORR). OS and TTF were compared between groups using the log-rank test and multivariable Cox regression models. ORR was assessed between the 3 groups using a multivariable logistic regression model. Results A total of 989 eligible patients were included in the analysis, with 438 (44.3%) nonsmokers, 415 (42%) former, and 136 (13.7%) current smokers. Former smokers were older and included more males, while other baseline characteristics were comparable between groups. Median follow-up for OS was 21.2 months. In the univariate analysis, a significant difference between groups was observed for OS (P = .027) but not for TTF (P = .9), with current smokers having the worse 2-year OS rate (62.8% vs 70.8% and 73.1% in never and former smokers, respectively). After adjusting for potential confounders, no significant differences in OS or TTF were observed among the 3 groups. However, former smokers demonstrated a higher ORR compared to never smokers (OR 1.45, P = .02). Conclusion Smoking status does not appear to independently influence the clinical outcomes to first-line ICI-based regimens in patients with mRCC. Nonetheless, patient counseling on tobacco cessation remains a crucial aspect of managing patients with mRCC, as it significantly reduces all-cause mortality.

Tobacco smoking induces metabolic reprogramming of renal cell carcinoma

Single-cell Multiomics Analysis Reveals Regulatory Programs in Clear Cell Renal Cell Carcinoma

From tobacco smoking to mutational signature: the role of epigenetic changes in human cancers

Tobacco smoke exposure is a driver of altered oxidative stress response and immunity in head and neck cancer

From Tobacco Smoking to Cancer Mutational Signature: a Mediation Analysis Strategy to Explore the Role of Epigenetic Changes

Impact of smoking status on clinical outcomes in patients with metastatic renal cell carcinoma treated with first-line immune checkpoint inhibitor-based regimens

Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival

Copper drives remodeling of metabolic state and progression of clear cell renal cell carcinoma

Modulation of Oxidative Phosphorylation and Mitochondrial Biogenesis by Cigarette Smoke Influence the Response to Immune Therapy in NSCLC Patients.

The impact of tobacco exposure on tumor microenvironment and prognosis in lung adenocarcinoma by integrative analysis of multi-omics data

Identifying a Novel Biomarker TOP2A of Clear Cell Renal Cell Carcinoma (ccrcc) Associated with Smoking by Co-Expression Network Analysis

Multi-omic profiling of clear cell renal cell carcinoma identifies metabolic reprogramming associated with disease progression

A Proteogenomic Analysis of Clear Cell Renal Cell Carcinoma in a Chinese Population.

The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis

Metabolite profiling of human renal cell carcinoma reveals tissue-origin dominance in nutrient availability

Sex differences in the tumor promoting effects of tobacco smoke in a cRaf transgenic lung cancer disease model

Curcumin Negatively Regulates Cigarette Smoke-Induced Renal Cell Carcinoma Epithelial–Mesenchymal Transition Through the ERK5/AP-1 Pathway

Metabolomics-based search for lung cancer markers among patients with different smoking status

Metabolic Reprogramming of Cancer Stem Cells and a Novel Eight-Gene Metabolism-Related Risk Signature in Clear Cell Renal Carcinoma

Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma